The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA
Remidex manufactures micronutrient premixes and nutraceuticals,
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Huwel’s diagnostic solutions leverage open RT-PCR system
ShunzymeX leverages a proprietary protease to streamline purification
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
Subscribe To Our Newsletter & Stay Updated
